Pfizer and BioNTech launch trial of Omicron vax
Financial Express Mumbai|January 26, 2022
PFIZER AND BIONTECH said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the Covid-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen.

Banking on volunteers in the United States, the companies plan to test the immune response generated by the Omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot for people who already received two doses of their original vaccine.

Continue reading your story on the app

Continue reading your story in the newspaper

MORE STORIES FROM FINANCIAL EXPRESS MUMBAIView All

Maruti May Stop S-Cross, Drive In SUV With Toyota

New model to take on Hyundai's Creta

2 mins read
Financial Express Mumbai
May 23, 2022

Pay At Card Machine By Using Your Hand

Walletmor's implant allows a user to pay at any terminal that accepts wireless payments by placing her hand on device

3 mins read
Financial Express Mumbai
May 23, 2022

More investments, less conflict on leaders' minds

WITH NEARLY 100 CEOs and over a dozen government leaders here for a rare springtime annual meeting of the World Economic Forum (WEF), the Indian contingent at this Swiss ski resort town is brimming with confidence when it comes to share their story of fighting the Covid-19 pandemic and attracting more investments.

1 min read
Financial Express Mumbai
May 23, 2022

Amazon aims to sublet, end leases of warehouse

AMAZON.COM, STUCK WITH too much warehouse capacity now that the surge in pandemic-era shopping has faded, is looking to sublet at least 10 million square feet of space and could vacate even more by ending leases with landlords, according to people familiar with the situation.

2 mins read
Financial Express Mumbai
May 23, 2022

Margins set firm's performance apart

Cigarette and FMCG saw impressive numbers; FY22 a year of recovery; 'Buy' retained with unchanged target price of ₹305

2 mins read
Financial Express Mumbai
May 23, 2022

Final quarter results missed estimates

Marketing losses likely to widen in Q1FY23, though higher GRM could partially offset impact; 'Buy' retained

2 mins read
Financial Express Mumbai
May 23, 2022

Infosys reappoints Salil Parekh as CEO & MD for another five years

INFOSYS ON SUNDAY said that its board of directors has reappointed Salil Parekh as CEO and MD for another five years.

1 min read
Financial Express Mumbai
May 23, 2022

Semiconductor shortage may hit telcos' revenues

Semiconductor shortage may hit telcos' revenues

2 mins read
Financial Express Mumbai
May 23, 2022

States in no hurry to cut VAT

Cut rates last Nov, say BJP-ruled states; excise cut translates to VAT cut too, counter Opposition states

4 mins read
Financial Express Mumbai
May 23, 2022

US, other APEC delegates walk out on Russian speaker

DELEGATES FROM THE United States and four other nations staged a walkout Saturday when a representative from Russia began his opening remarks at a meeting of trade ministers of the Asia-Pacific Economic Cooperation group in the Thai capital, officials said.

1 min read
Financial Express Mumbai
May 22, 2022
RELATED STORIES

Follow Your Nose

MEISSA VACCINES says a nasal spray is the best way to stop transmission of the coronavirus just breathe in | Could a nasal spray vaccine help end the pandemic?

10+ mins read
Bloomberg Businessweek
May 02, 2022

Waiting on mRNA Shots

Beijing refuses to allow Western vaccines even as the development of Chinese ones lags

4 mins read
Bloomberg Businessweek
May 02, 2022

The Promise Of Paxlovid

If Pfizer’s Covid-19 treatment is to help end the pandemic, more nations need rapid access

4 mins read
Bloomberg Businessweek
April 04, 2022

Will This Covid Star Get a Second Act?

Vir scored with monoclonal antibodies in the pandemic’s early days. Now it needs more

5 mins read
Bloomberg Businessweek
March 21 - 28, 2022 (Double Issue)

Time for a Boost

As changes to the vaccine policy are announced we unpack what you need to know

6 mins read
YOU South Africa
10 March 2022

MOST EFFECTIVE COVID VACCINES

CDC says mRNA works – China’s jabs are JUNK!

1 min read
Globe
February 21, 2022

Merck's Fumble Gives Pfizer a Win

It shelved a 10-year-old drug that’s provided a key component in a rival’s $17 billion Covid pill

6 mins read
Bloomberg Businessweek
February 07, 2022

MIRACLE COVID DRUG COMES WITH A CATCH!

A BREAKTHROUGH medication has been approved by the FDA to fight COVID-19, but it can cause potentially life-threatening interactions with a variety of widely prescribed drugs, warned experts.

1 min read
National Enquirer
January 31, 2022

Vacuna COVID-19 en niños: soluciona tus dudas

Los pequeños de 5 a 11 años ya pueden vacunarse frente al coronavirus. De la mano de dos expertos en Pediatría, resolvemos algunas cuestiones que preocupan a los padres.

3 mins read
Ser Padres
Issue 552

Hall Of Famers

Developing the Tech that Made covid Vaccines Possible

7 mins read
Newsweek
December 24, 2021